Patents Represented by Attorney James E. Nesbitt

Find this attorney in the Justia Lawyer Directory

  • Compounds and methods for treatment of chemotherapy-induced anemia
    Patent number: 7713986
    Abstract: The invention relates to methods and compounds for treating chemotherapy-induced anemia. In particular, methods for treating chemotherapy-induced anemia in subjects refractory to treatment with recombinant human erythropoietin are encompassed herein.
    Type: Grant
    Filed: June 15, 2006
    Date of Patent: May 11, 2010
    Assignee: FibroGen, Inc.
    Inventors: Todd W. Seeley, David Y. Liu, Stephen J. Klaus
  • Fat regulation
    Patent number: 7618940
    Abstract: The present invention provides methods and compounds for regulating fat metabolism and achieving fat homoeostasis in a subject. Methods and compound for regulating body weight, reducing body fat, and inducing weight loss are also provided, as are methods and compounds for treating or preventing obesity and for preventing or treating conditions associated with altered fat metabolism including, e.g., obesity, diabetes, atherosclerosis, etc.
    Type: Grant
    Filed: December 4, 2003
    Date of Patent: November 17, 2009
    Assignee: FibroGen, Inc.
    Inventors: Patrick D. Fourney, Volkmar Guenzler-Pukall, Stephen J. Klaus, Al Y. Lin, Thomas B. Neff, Todd W. Seeley
  • Recombinant gelatins
    Patent number: 7393928
    Abstract: The present invention relates to recombinant gelatins and compositions thereof, and methods of producing and using the same.
    Type: Grant
    Filed: May 27, 2005
    Date of Patent: July 1, 2008
    Assignee: FibroGen, Inc.
    Inventors: Robert C. Chang, Kari I. Kivirikko, Thomas B. Neff, David R. Olsen, James W. Polarek